15 February 2021

GSK Stockmann advises MLP on acquisition of RVM Group

GSK Stockmann provided comprehensive legal advice to the financial service provider MLP regarding the acquisition of the industrial insurance brokers RVM. For MLP this transaction is a first decisive step towards expanding their commercial and industrial insurance segment. Through this deal, MLP Assekuranzmakler Holding GmbH is taking over 100 percent of RVM Versicherungsmakler GmbH & Co. KG (whose headquarters are located in Eningen unter Achalm) including their key subsidiaries.

In the last few years, the MLP Group have succeeded in significantly expanding their portfolio for corporate and institutional clients as well as its B2B services through their acquisitions of DOMCURA and DEUTSCHLAND.Immobilien; these transactions were already carried out with legal support by GSK Stockmann. The financial service provider is now strategically expanding its market position in the field of commercial and industrial insurance. With the acquisition of the RVM Group, which has a well-established business model as an industrial insurance broker with a strong focus on medium-sized clients serving more than 2,500 companies, MLP aims to lay the foundation for further acquisitions of medium-sized market players in this field of consulting.

The total purchase price, which is in the mid double-digit million range, consists of an initial purchase price and a post-purchase price component that is linked to the quality of the business development until the end of 2022. The project will be implemented with economic effect from 1 January 2021, subject to approval by the antitrust authority.

With an interdisciplinary team extending across firm locations, GSK Stockmann comprehensively advised MLP on the drafting and negotiation of the purchase agreement as well as the preceding legal due diligence. In addition to providing support regarding corporate law, the firm also advised regarding banking and insurance supervisory law.

Advisers of MLP:

GSK Stockmann: Dr. Uwe Jäger, Dr. Jens Uwe Rügenhagen (both lead), Dr. Andreas C. Peters, Dr. Raoul Kreide (all Corporate), Dr. Philipp Kuhn (Employment Law), Stefan Koser (Finance), Daniela Eschenlohr (Banking Supervisory Law), Philippe Lorenz (Insurance Supervisory Law), Rebecca Comtesse (Finance), Dr. Harald Feiler (Compliance), Dr. Martin Hossenfelder (IP/IT), Wolfgang Jegodka (Anti-Trust Law); Associates: Stephanie Löhrius (Corporate), Nicole Deparade (Employment Law), Lieor Koblenz (Insurance Supervisory Law), Dr. Mechtild-Maria Siebke (Finance), Lukas Faron, Jana Wollenzin (both Corporate), Caroline J. Erler (Banking Supervisory Law), Jörg Wünschel (IP/IT).

Print


Press contact
presse@gsk.de
+49 30 203907-7763

Back

GSK Updates
  • 24 June 2022

    GSK Update: Accelerated construction of LNG terminals in Germany

    Read more
  • 06 May 2022

    GSK Update: Whistleblowing 2.0: What will the second draft of the Whistleblower Protection Act bring along?

    Read more
  • 25 April 2022

    GSK Update: Ban on public contracts with Russian companies

    Read more
Contact person

Dr. Uwe Jäger

Partner*

+49 6221 4566-0

uwe.jaeger@gsk.de

Dr. Jens Uwe Rügenhagen

Partner*

+49 6221 4566-12

jens.ruegenhagen@gsk.de

* Partner: a partner within the meaning of the German Partnership Companies Act.
   Local Partner: not a partner within the meaning of the German Partnership Companies Act.
CO2 Neutral